IL32 and neoplasm: Our previous studies also showed that IL-32 inhibited NF-κB and STAT3 in tumor growth models [8, 31] as well as acetoaminophen-induced liver injury and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson models (data not shown).